Full Length Research Paper
References
Abdulai T, Li Y, Zhang H, Tu R, Liu X, Zhang L, Dong X, Li R, Wang Y and Wang C (2019). Prevalence of impaired fasting glucose, type 2 diabetes and associated risk factors in undiagnosed Chinese rural population: the Henan Rural Cohort Study. BMJ open 9(8)e029628. |
|
Alema F, Seryogin G, Osinsky A., Osinsky A (2021). Ge doping of β-Ga2O3 by MOCVD. APL Materials 9(9):091102. |
|
Asiimwe D, Mauti GO, Kiconco R (2020). Prevalence and risk factors associated with type 2 diabetes in elderly patients aged 45-80 years at Kanungu District. Journal of diabetes research pp. 1-5. |
|
Awodele O, Osuolale JA. (2015). Medication adherence in type 2 diabetes patients: study of patients in Alimosho General Hospital, Igando, Lagos, Nigeria. African health sciences 15(2):513-522. |
|
Ayele A.G, Kumar P, Engidawork E (2021). Antihyperglycemic and hypoglycemic activities of the aqueous leaf extract of Rubus Erlangeri Engl (Rosacea) in mice. Metabolism Open 11:100118. |
|
Bahendeka S, Wesonga R, Mutungi G, Muwonge J, Neema S, Guwatudde D (2016). Prevalence and correlates of diabetes mellitus in Uganda: a population?based national survey. Tropical Medicine & International Health 21(3):405-416. |
|
Chaimum-Aom N, Chomko S, Talubmook C (2017). Toxicology and oral glucose tolerance test (OGTT) of Thai medicinal plant used for diabetes controls, Phyllanthus acidus L. (Euphorbiaceae). Pharmacognosy Journal 9(1). |
|
Chandran R, Parimelazhagan T, George BP (2017). Antihyperglycemic activity of the bark methanolic extract of Syzygium mundagam in diabetic rats. Alexandria Journal of Medicine 53(4):317-324. |
|
Chen Y, Lee K, Ni Z, He JC (2020). Diabetic kidney disease: challenges, advances, and opportunities. Kidney diseases 6(4):215-225. |
|
Chiwanga FS, Njelekela MA, Diamond MB, Bajunirwe F, Guwatudde D., Nankya-Mutyoba J, .Reid TG (2016). Urban and rural prevalence of diabetes and pre-diabetes and risk factors associated with diabetes in Tanzania and Uganda. Global health action 9(1):31440. |
|
Cho NH, Shaw J, Karuranga S, Huang Y, da Rocha Fernandes J, Ohlrogge A, Malanda B (2018). IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes research and clinical practice 138:271-281. |
|
Ciulei G (1964). Finium regundorum. Zeitschrift der Savigny-Stiftung für Rechtsgeschichte: Romanistische Abteilung 81(1):303-308. |
|
Cowan MM (1999). Plant products as antimicrobial agents. Clinical microbiology reviews 12(4):564-582. |
|
Davies MJ, D'Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, Rossing P, Tsapas A, Wexler DJ, Buse JB (2018). Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 61(12):2461-2498. |
|
Dimo T, Nouga C, Dzeufiet P, Nana P, Wembe P, Kamtchouing P (2007). Antidiabetic activity of Canarium schweinfurthii aqueous bark extract in streptozotocin type 1 diabetic rats. Phytochemistry and pharmacology III pp. 173-183. |
|
Gordon K (2001). The OECD guidelines and other corporate responsibility instruments. |
|
Gupta R, Mathur M, Bajaj VK., Katariya P, Yadav S, Kamal R, Gupta R. S (2012). Evaluation of antidiabetic and antioxidant activity of Moringa oleifera in experimental diabetes. Journal of diabetes 4(2):164-171. |
|
Jarald E, Joshi S, Jain D (2009). Antidiabetic activity of extracts and fraction of Zizyphus mauritiana. Pharmaceutical biology 47(4):328-334. |
|
Kakudidi E, Kirimuhuzya C, Anywar G, Katuura E, Kiguli J (2016a). Medicinal plants used in the management of noncommunicable diseases in Uganda. Medicinal Plants-Recent Advances in Research and Development pp. 397-418. |
|
Kakudidi E, Kirimuhuzya C, Anywar G, Katuura E, Kiguli J (2016b). Medicinal plants used in the management of noncommunicable diseases in Uganda. In Medicinal Plants-Recent Advances in Research and Development Springer pp. 397-418 |
|
Kamtchouing P, Kahpui S, Dzeufiet PDD, Tédong L, Asongalem E, Dimo T (2006). Anti-diabetic activity of methanol/methylene chloride stem bark extracts of Terminalia superba and Canarium schweinfurthii on streptozotocin-induced diabetic rats. Journal of Ethnopharmacology 104(3):306-309. |
|
Kouambou C, Dimo T, Dzeufiet P, Ngueguim F, Tchamadeu M, Wembe E, Kamtchouing P (2007). Antidiabetic and hypolipidemic effects of Canarium schweinfurthii hexane bark extract in streptozotocin-diabetic rats. PharmacologyOnline 1:209-219. |
|
MacDonald I, Oghale OU, Olajesu SC (2016). Anti-hyperglycemic effect of Canarium schwenfurthii fruit oil on wistar rats. Applied Medical Research 2(1):6-8. |
|
Mamun-or-Rashid ANM, Hossain MS, Hassan N, Dash B K, Sapon MA, Sen MK (2014). A review on medicinal plants with antidiabetic activity. Journal of Pharmacognosy and Phytochemistry 3(4):149-159. |
|
National Research Council (2010). Guide for the care and use of laboratory animals. |
|
Olawale AS (2012). Solid-liquid extraction of oils of African elemi's fruit. Agricultural Engineering International: CIGR Journal 14(2):155-161. |
|
Salama MS, Isunju JB, David SK, Muneza F, Ssemanda S, Tumwesigye NM (2021). Prevalence and factors associated with alcohol consumption among persons with diabetes in Kampala, Uganda: a cross sectional study. BMC Public Health 21:1-10. |
|
Sneddon LU, Halsey LG, Bury NR (2017). Considering aspects of the 3Rs principles within experimental animal biology. Journal of Experimental Biology 220(17):3007-3016. |
|
Ssenku JE, Okurut SA, Namuli A, Kudamba A, Tugume P, Matovu P, Walusansa A (2022). Medicinal plant use, conservation, and the associated traditional knowledge in rural communities in Eastern Uganda. Tropical Medicine and Health 50(1):39. |
|
Tugume P, Nambejja C, Nyakoojo C, Kamatenesi-Mugisha M (2019). Medicinal plant species used in the treatment of skin diseases in Katabi Subcounty, Wakiso District, Uganda. Ethnobotany Research and Applications 18:1-17. |
Copyright © 2023 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0